List of vaccine topics

Flu vaccine

This is a list of vaccine-related topics.

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe or its toxins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.[1]

Human vaccines

Viral diseases

Virus Diseases or conditions Vaccine(s) Brands
Hepatitis A virus Hepatitis A Hepatitis A vaccine Havrix, Avaxim, Vaqta, Epaxal, Twinrix, Biovac-A
Hepatitis B virus Hepatitis B Hepatitis B vaccine Sci-B-Vac Engerix-B, Recombivax HB, Elovac B, Genevac B, Shanvac B, Twinrix, Comvax, Pediarix, Pentabio
Hepatitis E virus Hepatitis E Hepatitis E vaccine Hecolin
Human papillomavirus Cervical cancer, Genital warts, anogenital cancers HPV vaccine Cervarix, Gardasil
Influenza virus Influenza Influenza vaccine FluMist, Fluzone, Influvac, Vaxigrip, Fluarix, Fluvirin, FluLaval, Agriflu, Flubio
Japanese encephalitis virus Japanese encephalitis Japanese encephalitis vaccine Ixiaro
Measles virus Measles MMR vaccine, MMRV vaccine Priorix, MMR II, Tresivac, Trimovax, ProQuad, Priorix Tetra
Mumps virus Mumps MMR vaccine, MMRV vaccine Priorix, MMR II, Tresivac, Trimovax, ProQuad, Priorix Tetra
Polio virus Poliomyelitis Polio vaccine Kinrix, Pediarix, Pentacel, Ipol,
Rabies virus Rabies Rabies vaccine Imovax, RabAvert
Rotavirus Rotaviral gastroenteritis Rotavirus vaccine Rotateq, Rotarix
Rubella virus Rubella MMR vaccine, MMRV vaccine Priorix, MMR II, Tresivac, Trimovax, ProQuad
Varicella zoster virus Chickenpox, Shingles Varicella vaccine, Shingles vaccine, MMRV vaccine Varivax, Zostavax, ProQuad, Priorix Tetra
Variola virus Smallpox Smallpox vaccine Dryvax, ACAM2000, Imvanex
Yellow fever virus Yellow fever Yellow Fever vaccine YF-VAX

Bacterial diseases

Bacterium Diseases or conditions Vaccine(s) Brands
Bacillus anthracis Anthrax Anthrax vaccines BioThrax
Bordetella pertussis Whooping cough DPT vaccine Boostrix, Adacel, Daptacel, Infanrix, Tripedia, Kinrix, Pediarix, Pentacel
Clostridium tetani Tetanus DPT vaccine Boostrix, Adacel, Decavac, Tenivac, Daptacel, Infanrix, Tripedia, Kinrix, Pediarix, Pentacel
Corynebacterium diphtheriae Diphtheria DPT vaccine Boostrix, Adacel, Decavac, Tenivac, Daptacel, Infanrix, Tripedia, Kinrix, Pediarix, Pentacel
Coxiella burnetii Q fever Q fever vaccine Q-Vax
Haemophilus influenzae type B (Hib) Epiglottitis, meningitis, pneumonia Hib vaccine Hiberix, Pentacel, ActHIB, Pedvax HIB
Mycobacterium tuberculosis Tuberculosis Tuberculosis (BCG) vaccine Tice BCG
Neisseria meningitidis Meningococcal meningitis Meningococcal vaccine Serotype C: Neisvac C and Meningitec. Serotypes A/C/W-135/Y: Mencevax, Nimenrix, Menveo. Serotype B: Bexsero
Salmonella typhi Typhoid fever Typhoid vaccine Typhim Vi, Typherix, Ty21a
Streptococcus pneumoniae Pneumococcal pneumonia Pneumococcal conjugate vaccine, Pneumococcal polysaccharide vaccine Pneumovax, Prevnar
Vibrio cholerae Cholera Cholera vaccine Dukoral, Shanchol

Vaccines under research

Vaccine components

Vaccine trials

Vaccination strategies

Vaccine safety

People

Developers of vaccines

Organizations, conferences and publications

Manufacturers
Other
Advocacy of anti-vaccination opinions

Legal aspects

Other

See also

References

  1. Loehr, Jamie (2009). "Vaccine Basics". The Vaccine Answer Book. Naperville, IL: Sourcebooks Inc. ISBN 1402223781.
  2. Kuschner, R. A.; Russell, K. L.; Abuja, M.; Bauer, K. M.; Faix, D. J.; Hait, H.; Henrick, J.; Jacobs, M.; Liss, A.; Lynch, J. A.; Liu, Q.; Lyons, A. G.; Malik, M.; Moon, J. E.; Stubbs, J.; Sun, W.; Tang, D.; Towle, A. C.; Walsh, D. S.; Wilkerson, D.; Adenovirus Vaccine Efficacy Trial Consortium (2013). "A phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of the live, oral adenovirus type 4 and type 7 vaccine, in U.S. Military recruits". Vaccine. 31 (28): 2963–2971. doi:10.1016/j.vaccine.2013.04.035. PMID 23623865.
  3. Kim, D. S.; Nam, J. H. (2010). "Characterization of attenuated coxsackievirus B3 strains and prospects of their application as live-attenuated vaccines". Expert Opinion on Biological Therapy. 10 (2): 179–190. doi:10.1517/14712590903379502. PMID 20088713.
  4. Schleiss, M. R. (2008). "Cytomegalovirus vaccine development". Current Topics in Microbiology and Immunology. Current Topics in Microbiology and Immunology. 325: 361–382. doi:10.1007/978-3-540-77349-8_20. ISBN 978-3-540-77348-1. PMC 2831992Freely accessible. PMID 18637516.
  5. Myles, R. (December 2, 2012). "France's Sanofi Pasteur to release Dengue fever vaccine". Digital Journal. Retrieved April 24, 2013.
  6. Pandya, J.; Gorchakov, R.; Wang, E.; Leal, G.; Weaver, S. C. (2012). "A vaccine candidate for eastern equine encephalitis virus based on IRES-mediated attenuation". Vaccine. 30 (7): 1276–1282. doi:10.1016/j.vaccine.2011.12.121. PMC 3283035Freely accessible. PMID 22222869.
  7. Erickson, D. (January 21, 2013). "Hamilton researchers help make breakthrough on Ebola vaccine". Billings Gazette. Retrieved May 29, 2013.
  8. Zhu, F. C.; Liang, Z. L.; Li, X. L.; Ge, H. M.; Meng, F. Y.; Mao, Q. Y.; Zhang, Y. T.; Hu, Y. M.; Zhang, Z. Y.; Li, J. X.; Gao, F.; Chen, Q. H.; Zhu, Q. Y.; Chu, K.; Wu, X.; Yao, X.; Guo, H. J.; Chen, X. Q.; Liu, P.; Dong, Y. Y.; Li, F. X.; Shen, X. L.; Wang, J. Z. (2013). "Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: A randomised, double-blind, placebo-controlled phase 2 clinical trial". The Lancet. 381 (9871): 1037. doi:10.1016/S0140-6736(12)61764-4.
  9. Pullen, L.C. (November 7, 2011). "Epstein-Barr Virus Vaccine May Soon Enter Phase 3 Trial". Medscape Today. Retrieved April 24, 2013.
  10. "Hepatitis C vaccine by Inovio could be tested in humans by end of year". Philadelphia Business Journal. January 9, 2013. Retrieved April 24, 2013.
  11. "Researchers a step closer to making HIV vaccine". Medical News Today. April 5, 2013. Retrieved April 24, 2013.
  12. Hanabuchi, S.; Ohashi, T.; Koya, Y.; Kato, H.; Hasegawa, A.; Takemura, F.; Masuda, T.; Kannagi, M. (2001). "Regression of human T-cell leukemia virus type I (HTLV-I)-associated lymphomas in a rat model: Peptide-induced T-cell immunity". Journal of the National Cancer Institute. 93 (23): 1775–1783. doi:10.1093/jnci/93.23.1775. PMID 11734593.
  13. De Thé, G.; Bomford, R.; Kazanji, M.; Ibrahim, F. (1994). "Human T cell lymphotropic virus: Necessity for and feasibility of a vaccine". Ciba Foundation Symposium. 187: 47–55; discussion 55–60. PMID 7796676.
  14. Hampton, T. (2006). "Marburg Vaccine Shows Promise: Offers Postexposure Protection in Monkeys". JAMA. 295 (20): 2346–2310. doi:10.1001/jama.295.20.2346.
  15. Sifferlin, A. (March 22, 2013). "Norovirus leading cause of intestinal disorders in kids". CNN. Retrieved April 24, 2013.
  16. Lindell, D. M.; Morris, S. B.; White, M. P.; Kallal, L. E.; Lundy, P. K.; Hamouda, T.; Baker, J. R.; Lukacs, N. W. (2011). Semple, Malcolm Gracie, ed. "A Novel Inactivated Intranasal Respiratory Syncytial Virus Vaccine Promotes Viral Clearance without Th2 Associated Vaccine-Enhanced Disease". PLoS ONE. 6 (7): e21823. doi:10.1371/journal.pone.0021823. PMC 3137595Freely accessible. PMID 21789184.
  17. Jiang, S.; Lu, L.; Du, L. (2013). "Development of SARS vaccines and therapeutics is still needed". Future Virology. 8: 1. doi:10.2217/fvl.12.126.
  18. Hall, R. A.; Khromykh, A. A. (2004). "West Nile virus vaccines". Expert Opinion on Biological Therapy. 4 (8): 1295–1305. doi:10.1517/14712598.4.8.1295. PMID 15268663.
  19. Shivakumar, K. M.; Vidya, S. K.; Chandu, G. N. (2009). "Dental caries vaccine". Indian Journal of Dental Research. 20 (1): 99–106. doi:10.4103/0970-9290.49066. PMID 19336869.
  20. Rudoler, N.; Baneth, G.; Eyal, O.; Van Straten, M.; Harrus, S. (2012). "Evaluation of an attenuated strain of Ehrlichia canis as a vaccine for canine monocytic ehrlichiosis". Vaccine. 31 (1): 226–233. doi:10.1016/j.vaccine.2012.10.003. PMID 23072894.
  21. McGuinness, R. (November 20, 2012). "Search for leprosy vaccine continues as disease still affects thousands". Metro News. Retrieved May 29, 2013.
  22. "Lyme Disease Vaccine". Lyme Info. Retrieved April 24, 2013.
  23. Bagnoli, F.; Bertholet, S.; Grandi, G. (2012). "Inferring Reasons for the Failure of Staphylococcus aureus Vaccines in Clinical Trials". Frontiers in Cellular and Infection Microbiology. 2. doi:10.3389/fcimb.2012.00016.
  24. Guilherme, L.; Ferreira, F. M.; Köhler, K. F.; Postol, E.; Kalil, J. (2013). "A Vaccine against Streptococcus pyogenes". American Journal of Cardiovascular Drugs. 13 (1): 1–4. doi:10.1007/s40256-013-0005-8. PMID 23355360.
  25. Cullen, P. A.; Cameron, C. E. (2006). "Progress towards an effective syphilis vaccine: The past, present and future". Expert Review of Vaccines. 5 (1): 67–80. doi:10.1586/14760584.5.1.67. PMID 16451109.
  26. Conlan, J. W. (2011). "Tularemia vaccines: Recent developments and remaining hurdles". Future Microbiology. 6 (4): 391–405. doi:10.2217/fmb.11.22. PMID 21526941.
  27. Titball, R. W.; Williamson, E. D. (2004). "Yersinia pestis (plague) vaccines". Expert Opinion on Biological Therapy. 4 (6): 965–973. doi:10.1517/14712598.4.6.965. PMID 15174978.
  28. Vogel, G. (March 20, 2013). "More Sobering Results for Malaria Vaccine". Science Magazine. Retrieved April 24, 2013.
  29. Siddiqui, A. A.; Siddiqui, B. A.; Ganley-Leal, L. (2011). "Schistosomiasis vaccines". Human Vaccines. 7 (11): 1192–1197. doi:10.4161/hv.7.11.17017. PMC 3323497Freely accessible. PMID 22048120.
  30. "Potential Chagas Vaccine Candidate Shows Unprecedented Efficacy". Science Daily. 26 March 2013. Retrieved 14 September 2013.
  31. "Human hookworm vaccine trial". Medical News Today. January 20, 2012. Retrieved April 24, 2013.
  32. Sanjit Bagchi (April 26, 2006). "Study raises hopes of vaccine for river blindness". SciDev Net. Retrieved April 24, 2013.
  33. La Greca, F.; Magez, S. (2011). "Vaccination against trypanosomiasis: Can it be done or is the trypanosome truly the ultimate immune destroyer and escape artist?". Human Vaccines. 7 (11): 1225–1233. doi:10.4161/hv.7.11.18203. PMC 3323498Freely accessible. PMID 22205439.
  34. Nakkazi, E. (March 12, 2012). "New vaccine trials to prevent visceral leishmaniasis". New Science Journalism. Retrieved June 16, 2013.
  35. Keller, D. M. (April 22, 2013). "Alzheimer's Vaccine Shows Efficacy Without Adverse Effects". Medscape News. Retrieved May 29, 2013.
  36. McFadden, M. (October 11, 2012). "Revolutionary breast cancer vaccine 100% effective in mice: awaits human trials". WNDU. Retrieved May 12, 2013.
  37. "Ovarian cancer vaccine shows promise in trial". Fox News. April 8, 2013. Retrieved April 24, 2013.
  38. Jonhson, K. (March 21, 2013). "Prostate Cancer Vaccine Shows Promise". Medscape Today. Retrieved April 24, 2013.
This article is issued from Wikipedia - version of the 10/11/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.